Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
awww okay! Thank you....I appreciate the info. I have a modest position too. I guess I'll sit on and hold while longer.
Thanks and have a great week!
3
What am I missing...no volume to speak of so how can anyone sell and make $ if no ones buying?
Aso, does anyone know what the link between RNWF and HPST is?
TIA
3BB
Good morning! Who’s the 50,000 share block at .281?
Hello all. Nice pull together of situation Coop.
Excellent perspective....thank you Trow
Thank you for all of this wonderfully solid dd.
Agree. Thank you for all you do Sello!
My alert/news hit my inbox at 8:14am 1/29
Decent close for the week. Looking forward to the next 30-60 days. Slow and steady rise....
All such great explanations. Thank you
Good to know....thx!
Sounds about right!
How strange....lol. No conspiracy theory then...thanks for additional insight.
Another poster made such statement yesterday. When I was looking at trades I just find it off that we'd have 5 share trades, 11 share trades for a stock that sits at $3.25. Just me but it seems odd. I don't make any moves off anything other than dd though so it doesn't drive my decisions....just thought odd.
TIA...appreciate all of your posts and insight.
3BB
Ok folks. I know the 14 typical mm trade signals but I’m betting there’s more to it. What does a trade of 11 or trade if 5 mean? Who in the h*ll trades 5 share of a $3 stock.
TIA
3BB
Just not right....lol
hhmmm interesting...thank you for elaborating. I'll look more in to that. Thanks again!!
Excellent DD package!
Hey Roadster....You wrote - Also , there was a MM signal trade of 400 late. What do you mean by this. What about the 255 trade shortly before the 400? What was the signal?
TIA
3BB
Nice...good to see you back with us on the board!
Very...very well said PB.
Great buying opportunity. I’m adding...
Me too...bought more...appreciate the dip moment
WTF is all I have to say....so frustrating. Being a LT hold i'm just going to stop looking at this one.
Happy Days FSR
3BB
Good morning all. Such an nice week thus far. Looking forward to continued progress forward.
Just a RE-POST of a NOV 1 article....
The Exciting Rise of Cannagistics Inc (OTCMKTS: CNGT) 2
BY BOE RIMES ON NOVEMBER 1, 2020MEDIA & TECHNOLOGY, MICRO CAP INSIDER, SMALL CAPS
Post Views: 2,549
Cannagistics Inc (OTCMKTS: CNGT) is making a big move up the charts in recent weeks off its double zero lows to recent highs well into penny land. The stock has quickly attracted legions of shareholders and has established itself as a volume leader in small caps. Reverse Merger plays are some of the biggest runners in small caps rivaling only biotechs in their ability to make historic shot term gains.
CNGT has been heating up since the Company got new CEO Jam Rob Gietl on board who was most recently, Until March 2020 the Interim CEO of Availa Bio, Inc., a company engaged in the development of numerous patented and patent pending products in the health and wellness space. According to an 8k filed by PBIO; “Pressure BioSciences, Inc. entered into a binding letter of intent to merge with Cannaworx Holdings, Inc. Pursuant to the Second Amendment, the parties extended the September 30, 2020 deadline to October 31, 2020.
Cannagistics Inc (OTCMKTS: CNGT) is a complete end to end supply chain management company, with advanced technology and operating service subsidiaries. Our Proprietary technology platforms will provide a turnkey onramp for access and services worldwide [for growers, processors, and buyers]to tap into the ever-expanding worldwide cannabis marketplace.Global 3PL. operates bonded warehousing in Mississauga (the first Canadian company to obtain a license for cannabis), which shall serve both the cannabis and general commodities industries with Just In Time Inventory, ground, air, and ocean freight transport, international freight forwarding, and Custom House Brokerage. Cannagistics also entered into a letter of intent to acquire anISO 9000 research and testing lab looking to expand its operations to Florida, Las Vegas, Oregon, California, Canada, and Bogotá, Colombia. We will also pursue operations in the E.U., based in Poland.
The Company is led by CEO by new CEO Rob Gietl was most recently, Until March 2020 the Interim CEO of Availa Bio, Inc., a company engaged in the development of numerous patented and patent pending products in the health and wellness space. From April 2017 to February 2019, Mr. Gietl was CEO of MYM Nutraceuticals Inc., an emerging bio-pharmaceutical company and distributor of medical cannabis products. He previously served from September 2015 to March 2017as the Director of Business Development at NRI Global Inc. where he led industrial acquisitions, environmental remediation and global sales of reusable assets and commodities
I show it at .0064
Any speculation that this could be SPAC positioning? I thought the same thing about the 1mm non refundable $$. One would have to assume that there is more to this relationship than revealed to date.
Thoughts??
Agree....nice to see!
If we can push to .62, hold and level out before next leg up that would be a huge long term positive. I’m good with .75 too though!!
News just hit the wires....
https://finance.yahoo.com/news/relief-therapeutics-acer-therapeutics-sign-133500143.html
Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
Acer Therapeutics Inc.
Mon, January 25, 2021, 7:35 AM
Acer to receive $1 million payment to obtain exclusivity and a $4 million loan from Relief
Companies working toward negotiation and execution of a definitive collaboration
and license agreement by June 30, 2021
GENEVA and NEWTON, Mass., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Relief Therapeutics Holding AG (SIX: RLF, OTCQB: RLFTF)(“Relief”), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, and Acer Therapeutics Inc. (Nasdaq: ACER)(“Acer”), a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that the companies have signed an Option Agreement providing exclusivity for the right to negotiate a potential collaboration and license agreement for worldwide development and commercialization for ACER-001. ACER-001 (sodium phenylbutyrate) powder is a taste-masked, immediate release proprietary formulation in development for the treatment of urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD).
Under the terms of the Option Agreement, Acer will receive from Relief a $1 million non-refundable payment in return for exclusivity until June 30, 2021 to negotiate and enter into a definitive collaboration and license agreement between Acer and Relief for the development of ACER-001. Further, in connection with entering into the Option Agreement, Relief will make a $4.0 million loan to Acer. The loan, which will be secured by a lien on all of Acer's assets, will bear interest at the rate of 6% per annum and will be due in one year.
Under the terms of the proposed collaboration and license agreement, the key terms of which are set forth in the Option Agreement, if a definitive agreement is executed pursuant to these terms and closed by June 30, 2021, Acer will receive $15 million in cash (net $10 million, inclusive of the $1 million payment and offset by a repayment of the $4 million loan from Relief). In addition, Relief will agree to pay up to $20 million in U.S. development and commercial launch costs for the UCDs and MSUD indications. Further, Acer will retain development and commercialization rights in the U.S., Canada, Brazil, Turkey and Japan. The companies will split net profits from Acer’s territories 60:40 in favor of Relief. Relief will also license the rights for the rest of the world, where Acer will receive from Relief a 15% net sales royalty on all revenues received in Relief’s territories. Acer could also receive a total of $6 million in milestones based on the first European (EU) marketing approvals for UCDs and MSUD. There can be no assurance, however, that a definitive agreement will be successfully negotiated and executed between the parties on these terms, on other mutually acceptable terms, or at all. Except for the $1.0 million upfront payment to Acer and the $4.0 million one-year secured loan from Relief to Acer, the remaining proposed terms of the collaboration are not binding and are subject to change as a result of further diligence by Relief and negotiation of a definitive collaboration and license agreement between the parties.
Sorry for your loss DrBones
CSTI always sits on both sides at the low and the high...at least that's what i've noticed
Dipped my toe today...
Agree!!
Great read...thank you for posting.
Nice find thank you for sharing.
What prompts you to say/believe that? Jc...
3 Stocks To Watch This Week! $CEOS, $LRSV, & $HPST
January 18, 2021|#Cannabis, #CBD, #Mushrooms, #Psilocybin, #SHROOMS, $CEOS, $HPST, $LRSV
Hempstract, Inc, (OTC PINK:HPST)(the "Company"), Jan 5, 2021 announced it has completed the extraction process on 36,821 of raw hemp resulting in 4,050 pounds of extracted product. Representing a major milestone in the Company's production and business development plans. The Company will be handling all pre-orders and market orders in house, to maximize sales revenues.
Richard Hawkins, the Company's Chief Executive Officer, commented: "As a company we've seen an increase in demand for concentrates and we're so thrilled to be kicking of the new year with the completion of this first extraction to begin to answer this increasing demand."
About Hempstract, Inc.
Hempstract, Inc. (OTC PINK:HPST) is a Nevada registered publicly-traded company. Hempstract production operations located in Warden, Washington offers business partners premium CBD Solutions they can trust at competitive prices. Hempstract and its laboratories go to great lengths to ensure that all of its solutions are of the highest quality and control standards and provides pure, high-quality, and safe, CBD isolate and oil to its customers. HPST has "verified" outstanding shares of 93,485,744.
Nice section of shareholder letter several weeks back....Thought worth re-iterating...
While the ABTC team has been hard at work operationalizing our innovative multi-pronged battery material production platform, the industry broadly continues to grow as well. Growth in demand for lithium-ion batteries is predicted by industry researchers to grow by over ten-fold over the next ten years, while over the same period there are limited announcements for new production sources of domestic US based battery metals, including lithium, nickel, cobalt, or manganese. We expect increased pressure on the prices of domestically sourced battery metals, and increased reliance on foreign sourced battery metals.
These exciting industry trends support and validate our business model to increase the production of domestic US sourced battery metals. We look forward to continuing to grow our business as an industry leader in the closed loop production of the materials that fuel the new energy revolution.
Thank you for being a part of American Battery Metals Corporation, and now—American Battery Technology Company.